MedTrace Logo

Community-based Sport Programme and Type 2 Diabetes

NCT02548702 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4032

Last updated 2015-09-14

No results posted yet for this study

Summary

The Fit4Life intervention aims to engage inactive patients with type 2 diabetes in a community-based sport intervention, with the aim being that all participants complete 1 x 30 min session of physical activity/exercise per week across the 12 months they are involved in the intervention (total study duration 3 years).

The aim of the Fit4Life intervention is to slow the progression of disease symptoms and to improve quality of life in those diagnosed with type 2 diabetes. The aim of this research study is thus to evaluate the effectiveness of the intervention in achieving these aims. The hypothesis is that involvement in the Fit4Life programme will increase physical activity, reduce type 2 diabetes disease symptoms and enhance self-reported quality of life in male and female patients aged 35-64.

Conditions

Interventions

BEHAVIORAL

Fit4Life

Fit4Life is a programme whereby patients with type 2 diabetes are counselled and then allocated to a community-based sport programme based on their interests and perceived barriers to participation

Sponsors & Collaborators

  • Community Sport Trust

    collaborator UNKNOWN

  • Sport Nottinghamshire

    collaborator UNKNOWN

  • Sport England

    collaborator OTHER

  • Nottingham City Clinical Commissioning Group

    collaborator OTHER

  • NHS North and East Nottinghamshire Clinical Commissioning Group

    collaborator OTHER

  • NHS Lincolnshire West Clinical Commissioning Group

    collaborator OTHER

  • NHS Rushcliffe Clinical Commissioning Group

    collaborator OTHER

  • Nottingham City Council

    collaborator UNKNOWN

  • Nottinghamshire County Council

    collaborator UNKNOWN

  • Nottingham Trent University

    lead OTHER

Principal Investigators

  • Mary E Nevill, PhD · Nottingham Trent University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02548702 on ClinicalTrials.gov